Anticytoplasmic antibodies (Ro and La) and connective tissue disease: clinical and biological heterogeneity of systemic lupus
Guillet, G.; Gin, H.; Aubertin, J.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(8): 513-516
1983
ISSN/ISBN: 0037-1777 PMID: 6302893 Document Number: 217986
Document emailed within 1 workday
Related Documents
Parker, M.D. 1973: Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease Journal of Laboratory and Clinical Medicine 82(5): 769-775Thomas, J.W.; Vertkin, A.; Nell, L.J. 1987: Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes Journal of Rheumatology 14(4): 732-735
Vandergheynst, F.; Ocmant, A.; Sordet, C.; Humbel, R.L.; Goetz, J.; Roufosse, F.; Cogan, E.; Sibilia, J. 2006: Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients Clinical and Experimental Rheumatology 24(2): 129-133
Cook, A.D.; Mackay, I.R.; Cicuttini, F.M.; Rowley, M.J. 1997: IgG subclasses of antibodies to type Ii collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases Journal of Rheumatology 24(11): 2090-2096
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Sönnichsen, N.; Ziegler, H.; Barthelmes, H.; Albrecht-Nebe, H.; Schulze, P.; Brenke, A. 1988: Mixed connective tissue disease (Sharp). Nosologic entity or a subgroup of systemic lupus erythematosus? Dermatologische Monatschrift 174(3): 137-141
Sinico, R.A.; Radice, A. 2005: The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 22(Suppl 33): S21-S26
Paradowska-Gorycka, A.; Wajda, A.; Stolarek, I.; Felis-Giemza, A.; Walczyk, M.; Nałecz-Janik, J.; Olesińska, M. 2019: Is the T-G-CT-G SNRNP70 haplotype another proof that mixed connective tissue disease is distinct from systemic lupus erythematosus and systemic sclerosis? a novel gene variant in SNRNP70 gene Clinical and Experimental Rheumatology 37 Suppl 119(4): 32-40
Edworthy, S.M. 1995: A database for systemic lupus erythematosus and systemic connective tissue disorders Rheumatic Diseases Clinics of North America 21(2): 501-525
Pallis, M.; Hopkinson, N.; Powell, R. 1991: Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease Journal of Rheumatology 18(10): 1532-1536
Malaviya, A.N.; Adhar, G.C.; Pasricha, J.S. 1979: Connective tissue disease in India. III. Clinical and immunological profile of progressive systemic sclerosis Journal of the Association of Physicians of India 27(5): 395-400
Malaviya, A.N.; Rajagopalan, P.; Venkitaraman, R. 1984: Use of monoclonal antibodies to define peripheral blood lymphocyte subsets in systemic connective tissue diseases Indian Journal of Medical Research 80: 196-202
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
Brandt, J.; Maier, T.; Rudwaleit, M.; Kühl, U.; Hiepe, F.; Sieper, J.; Braun, J. 2002: Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis Clinical and Experimental Rheumatology 20(1): 80-84
Houtman, P.M.; Kallenberg, C.G.; Limburg, P.C.; Huitema, M.G.; van Rijswijk, M.H.; The, T.H. 1985: Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease Clinical and Experimental Immunology 62(3): 696-704
Haugeberg, G.; Brodin, C.; Johnsen, V. 1995: Systemic sclerosis. a rare connective tissue disease with manifestations in many organs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(29): 3619-3621
Pepmueller, P.H. 2016: Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology Missouri Medicine 113(2): 136-140
Diaz-Jouanen, E.; Llorente, L.; Ramos-Niembro, F.; Alarcon-Segovia, D. 1977: Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease Journal of Rheumatology 4(1): 4-10
Myckatyn, S.O.; Russell, A.S. 2003: Outcome of positive antinuclear antibodies in individuals without connective tissue disease Journal of Rheumatology 30(4): 736-739
Cunningham, P.H.; Andrews, B.S.; Davis, J.S. 1980: Immune complexes in progressive systemic sclerosis and mixed connective tissue disease Journal of Rheumatology 7(3): 301-308